New checkpoint blockers begin human trials. [J Natl Cancer Inst. 2005] - PubMed

New drugs target hypoxia response in tumors. [J Natl Cancer Inst. 2005]
New drugs target hypoxia response in tumors.
Garber K. J Natl Cancer Inst. 2005 Aug 3; 97(15):1112-4.
Review Epothilone D (Kosan/Roche). [Curr Opin Investig Drugs. 2004]
Review Epothilone D (Kosan/Roche).
Kolman A. Curr Opin Investig Drugs. 2004 Jun; 5(6):657-67.
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. [Mol Cancer Ther. 2006]
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.
Bugler B, Quaranta M, Aressy B, Brezak MC, Prevost G, Ducommun B. Mol Cancer Ther. 2006 Jun; 5(6):1446-51.
Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. [Mol Cancer Ther. 2007]
Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint.
Sha SK, Sato T, Kobayashi H, Ishigaki M, Yamamoto S, Sato H, Takada A, Nakajyo S, Mochizuki Y, Friedman JM, et al. Mol Cancer Ther. 2007 Jan; 6(1):147-53.
Review OSI-461 (OSI). [Curr Opin Investig Drugs. 2004]
Review OSI-461 (OSI).
Galmarini CM. Curr Opin Investig Drugs. 2004 Jun; 5(6):648-56.

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. [J Transl Med. 2009]
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.
Azorsa DO, Gonzales IM, Basu GD, Choudhary A, Arora S, Bisanz KM, Kiefer JA, Henderson MC, Trent JM, Von Hoff DD, et al. J Transl Med. 2009 Jun 11; 7:43. Epub 2009 Jun 11.
Regulation of Chk1 by its C-terminal domain. [Mol Biol Cell. 2008]
Regulation of Chk1 by its C-terminal domain.
Kosoy A, O'Connell MJ. Mol Biol Cell. 2008 Nov; 19(11):4546-53. Epub 2008 Aug 20.
Review Turning off the G2 DNA damage checkpoint. [DNA Repair (Amst). 2008]
Review Turning off the G2 DNA damage checkpoint.
Calonge TM, O'Connell MJ. DNA Repair (Amst). 2008 Feb 1; 7(2):136-40. Epub 2007 Sep 11.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

New checkpoint blockers begin human trials.
New checkpoint blockers begin human trials.
J Natl Cancer Inst. 2005 Jul 20 ;97(14):1026-8.

PubMed
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1...
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.
Nature. 1998 Oct 1 ;395(6701):507-10.

PubMed
Prophylactic antibiotics for burns patients: systematic review and meta-analysis...
Prophylactic antibiotics for burns patients: systematic review and meta-analysis.
BMJ. 2010 Feb 15 ;340:c241. doi: 10.1136/bmj.c241.

PubMed
Effect of human rotavirus vaccine on severe diarrhea in African infants.
Effect of human rotavirus vaccine on severe diarrhea in African infants.
N Engl J Med. 2010 Jan 28 ;362(4):289-98.

PubMed
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
N Engl J Med. 2010 Jan 28 ;362(4):299-305.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed